The long QT interval syndromes and torsade de pointes are potentially life-threatening conditions caused by various agents, conditions, and genetic defects. The mechanisms responsible for these conditions and available treatment options for them are reviewed.
Background-Optical mapping of cytosolic calcium transients in intact mammalian hearts is now possible using long-wavelength [Ca 2ϩ ] i indicators. We propose that beat-to-beat [Ca 2ϩ ] i transient alternans during ischemia may lead to spatial and temporal heterogeneity of calcium-activated membrane currents. Methods and Results-To test this hypothesis, isolated rabbit hearts were loaded with the fluorescent [Ca 2ϩ ] i indicator, rhod-2 AM, and imaged at 300 frames/sec during blood-perfused ischemic trials. High-quality [Ca 2ϩ ] i transients were recorded in each of 8 hearts. [Ca 2ϩ ] i transient alternans was never present in control records but occurred in each of the hearts during ischemia, with onset after 2 to 4 minutes. Alternans was confined to circumscribed regions of the heart surface 5 to 15 mm across. Multiple regions of alternans were found in most hearts, and regions that were out of phase with one another were found in 6 hearts. Quantitative maps of alternans were constructed by calculating an alternans ratio. This ratio behaved as a continuous variable that reached a maximum value in the center of the regions with alternans.Conclusions-These results demonstrate marked spatial heterogeneity of the [Ca 2ϩ ] i transient during the early phase of ischemia, which could produce electrical instability and arrhythmias in large mammalian hearts. (Circulation. 2001;
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.